Abstract:OBJECTIVE The authors analyzed the efficacy of intensive chemotherapy followed by reduced-dose and reduced-field irradiation for intracranial germ cell tumors (GCTs) and evaluated the long-term late effects caused by chemoradiotherapy (CRT). METHODS The authors performed a retrospective study. The subjects were 24 patients who received CRT between April 1994 and April 2015. After surgery, intensive chemotherapy followed by reduced-dose and reduced-field irradiation was administered. For those with pure germinoma, who comprised the “good prognosis” group, five courses of conventional-dose chemotherapy (CDC) were administered, and radiotherapy (24 Gy) was applied to the whole ventricle. For all others, defined as the “intermediate and poor prognosis” group, two or three courses of CDC and high-dose chemotherapy were administered with peripheral blood stem cell transplantation and radiotherapy (24–30 Gy) applied to the whole ventricle or a larger field with or without local boost irradiation (20 Gy), which was applied as needed. RESULTS The median period of follow-up was 112.5 months (range 28–261 months), and the 5-/10-year overall and progression-free survival rates were 100%/83.5% and 91.3%/86.5%, respectively. The 5-/10-year overall survival rates determined based on the histological subtypes were 100%/100% for pure germinoma and 93.8%/78.7% for others, respectively. The late toxicities were as follows: endocrine disorder (33% in pure germinoma, 56% in others), involuntary movements (17% in pure germinoma, 39% in others), ear and labyrinth disorders (17% in pure germinoma, 33% in others), and psychiatric disorders (0% in pure germinoma, 33% in others). Nineteen of 24 patients underwent MRI (T2*- or susceptibility-weighted imaging) after radiotherapy, and 16 (84%) of those 19 patients had microbleeds detected, while 2 (10.5%) had radiation-induced cavernous vascular malformations detected. CONCLUSIONS Intensive chemotherapy followed by reduced-dose and reduced-field irradiation for intracranial GCTs had the same outcome as that reported in the literature, but late adverse effects after treatment were observed. Almost all of the complications were relatively mild but had the potential to lead to psychiatric disorders and intracranial hemorrhaging. ABBREVIATIONS AFP = alpha-fetoprotein; CDC = conventional-dose chemotherapy; CMB = cerebral microbleed; CRT = chemoradiotherapy; CSI = craniospinal irradiation; EP = etoposide and cisplatin; GCT = germ cell tumor; HCG = human chorionic gonadotropin; HDC = high-dose chemotherapy; ICE = ifosfamide, cisplatin, and etoposide; NGGCT = nongerminomatous GCT; OS = overall survival; PBSCT = peripheral blood stem cell transplantation; PFS = progression-free survival; RICM = radiation-induced cavernous malformation; STGC = syncytiotrophoblastic giant cell; SWI = susceptibility-weighted imaging.

RTHP-31. EMERGENCY RADIOTHERAPY IN INTRACRANIAL GERM CELL TUMORS (GCTS) PATIENTS WITH KPS≤ 40: ARETROSPECTIVE ANALYSIS OF 27 CASES

RTHP-13. EMERGENCY RADIOTHERAPY FOR PATIENTS WITH RAPIDLY DETERIORATING INTRACRANIAL GERM CELL TUMORS

Pituitary Dysfunction in Patients with Intracranial Germ Cell Tumors Treated with Radiotherapy

Long-term follow-up of intensive chemotherapy followed by reduced-dose and reduced-field irradiation for intracranial germ cell tumor

Treatment of primary intracranial germ cell tumors: Single center experience with 42 clinically diagnosed cases.

RARE-20. ANALYSIS OF CLINICAL FEATURES ON DEATH FROM INTRACRANIAL GERM CELL TUMORS (GCTS): ARETROSPECTIVE COHORT STUDY

Epid-36. Clinical Features Of 614 Primary Intracranial Germ Cell Tumors: An 15-Year Experience Of A Single Center In China

[Treatment Outcome of Primary Central Nervous System Germ Cell Tumors after Combined Therapy: a Report of 23 Cases].

EPID-15. AGE AND DOSIMETRIC IMPACTS ON RADIOTHERAPY ASSOCIATED GROWTH IMPAIRMENT FOR PATIENTS WITH INTRACRANIAL GERM CELL TUMORS (Gcts)

CTNI-60. NEOAJUVANT CHEMOTHERAPY FOLLOWED BY CRANIOSPINAL IRRADIATION FOR INTRACRANIAL NGGCTS: CLINICAL OUTCOMES AND AGE-STRATIFIED TOXICITIES IN A COHORT OF 111 PATIENTS

Survival Outcomes, Hematologic Complications and Growth Impairment after Sequential Chemoradiotherapy in Intracranial NGGCTs: a Retrospective Study

GCT-30. TREATMENT OF PRIMARY INTRACRANIAL GERM CELL TUMORS: SINGLE INSTITUTION EXPERIENCE OF 74 CASES WITHOUT HISTOLOGICAL CONFIRMATION

RTHP-24. CLINICAL FEATURES OF BASAL GANGLIA GERM CELL TUMORS AND ITS CLINICAL OUTCOMES

Gamma Knife Radiosurgery (GKRS) for Pineal Region Tumors: a Study of 147 Cases

Clinical Analysis of Intracranial Germinoma's Craniospinal Irradiation Using Helical Tomotherapy.

Diagnosis and Treatment of Intracranial Germ Cell Tumors (Clinical Analysis of 38 cases)

Radt-31. Embracing Hypofractionated Radiotherapy For Glioblastoma In A Resource Constrained Setting

Gamma knife radiosurgery of epidermoid tumors: an analysis of treatment results of eight patients

Dosimetric Impacts on Height Development after Radiotherapy for Intracranial Non-germinomatous Germ Cell Tumours

RTHP-05. NON-OPERATIVE TREATMENT OF NON-GERMINOMATOUS GERM CELL TUMORS OF THE PINEAL REGION

Emergency Irradiation of 3.4gy/2f in Pineal Gland Germinoma Patients with Symptomatic Hydrocephalus.